Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.15 SEK | +3.57% | +3.95% | -10.87% |
02-06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
02-06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.02M 4.23B | Sales 2025 * | 620M 56.72M 4.53B | Capitalization | 381M 34.8M 2.78B |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.56M 205M | Net income 2025 * | 41M 3.75M 299M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.13M 569M | Net Debt 2025 * | 75.63M 6.92M 552M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | 228 |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | +1.43% | ||
1 week | +3.95% | ||
Current month | +0.70% | ||
1 month | +1.63% | ||
3 months | -12.89% | ||
6 months | +8.70% | ||
Current year | -10.87% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 30/09/22 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 31/12/20 | |
Chairman | 72 | 31/12/20 | |
Director/Board Member | 57 | 31/12/13 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 10.15 | +3.57% | 41 120 |
26/04/24 | 9.8 | +4.03% | 39,281 |
25/04/24 | 9.42 | -1.46% | 19,433 |
24/04/24 | 9.56 | -1.44% | 1,521 |
23/04/24 | 9.7 | +0.83% | 2,928 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 03:47 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.87% | 34.71M | |
+8.44% | 219B | |
+7.08% | 183B | |
+11.28% | 133B | |
+25.62% | 108B | |
+1.37% | 63.06B | |
+12.21% | 52.02B | |
-0.62% | 48.2B | |
+0.00% | 40.37B | |
+13.22% | 39.35B |
- Stock Market
- Equities
- BOUL Stock